Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Robertsen

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|September 24, 2020
Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body WeightChristine Wegler, Luna Prieto Garcia, Signe Klinting, et al.
Clinical Pharmacology and Therapeutics|February 14, 2022
Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With ObesityChristine Wegler, Jacek R Wiśniewski, Ida Robertsen, et al.
Clinical Pharmacology and Therapeutics|May 21, 2024
Oral Drug Dosing After Gastric Bypass and Diet-Induced Weight Loss: Simpler Than We Think? Lessons Learned From the COCKTAIL StudyKine Eide Kvitne, Jøran Hjelmesæth, Markus Hovd, et al.
Transplantation|April 29, 2017
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal TransplantationErlend Johannessen Egeland, Ida Robertsen, Monica Hermann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 6, 2019
A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with ObesityVeronica Krogstad, Alexandra Peric, Ida Robertsen, et al.
Therapeutic Drug Monitoring|March 27, 2018
Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core BiopsiesVeronica Krogstad, Nils T Vethe, Ida Robertsen, et al.
Clinical Pharmacokinetics|November 22, 2023
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight IndividualsKine Eide Kvitne, Markus Hovd, Line Kristin Johnson, et al.
Clinical and Translational Science|August 29, 2022
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesityKine Eide Kvitne, Anders Åsberg, Line K Johnson, et al.
Therapeutic Drug Monitoring|June 11, 2020
Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert PanelFlorian Lemaitre, Nils T Vethe, Antonio D'Avolio, et al.
Journal of Pharmaceutical Sciences|October 22, 2020
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 EnzymesVeronica Krogstad, Alexandra Peric, Ida Robertsen, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|September 24, 2020
Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body WeightChristine Wegler, Luna Prieto Garcia, Signe Klinting, et al.
Clinical Pharmacology and Therapeutics|February 14, 2022
Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With ObesityChristine Wegler, Jacek R Wiśniewski, Ida Robertsen, et al.
Clinical Pharmacology and Therapeutics|May 21, 2024
Oral Drug Dosing After Gastric Bypass and Diet-Induced Weight Loss: Simpler Than We Think? Lessons Learned From the COCKTAIL StudyKine Eide Kvitne, Jøran Hjelmesæth, Markus Hovd, et al.
Transplantation|April 29, 2017
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal TransplantationErlend Johannessen Egeland, Ida Robertsen, Monica Hermann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 6, 2019
A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with ObesityVeronica Krogstad, Alexandra Peric, Ida Robertsen, et al.
Therapeutic Drug Monitoring|March 27, 2018
Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core BiopsiesVeronica Krogstad, Nils T Vethe, Ida Robertsen, et al.
Clinical Pharmacokinetics|November 22, 2023
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight IndividualsKine Eide Kvitne, Markus Hovd, Line Kristin Johnson, et al.
Clinical and Translational Science|August 29, 2022
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesityKine Eide Kvitne, Anders Åsberg, Line K Johnson, et al.
Therapeutic Drug Monitoring|June 11, 2020
Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert PanelFlorian Lemaitre, Nils T Vethe, Antonio D'Avolio, et al.
Journal of Pharmaceutical Sciences|October 22, 2020
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 EnzymesVeronica Krogstad, Alexandra Peric, Ida Robertsen, et al.
Pageof 5